Steven Miller compensation by year
CATALYST PHARMACEUTICALS Summary Compensation Table · all 4 fiscal years held| Component | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Salary | $496,827 | $525,000 | $560,000 | $582,000 |
| Bonus | $300,000 | $346,500 | $352,800 | $349,200 |
| Stock awards | $1,091,560 | $503,995 | $523,797 | $1,088,998 |
| Option awards | $1,574,196 | $2,016,003 | $2,095,377 | $1,633,581 |
| Non-equity incentive | $0 | $0 | $0 | $0 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 |
| All other | $12,200 | $13,200 | $13,800 | $38,000 |
| Total | $3,474,783 | $3,404,698 | $3,545,774 | $3,691,779 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: CATALYST PHARMACEUTICALS, INC. 10-K/A filed April 30, 2026, accession 0001193125-26-197490, and prior-year filings.
How this page was built: the CATALYST PHARMACEUTICALS, INC. filed document, accession 0001193125-26-197490. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| PSU | 47,826 | $0 | — |
| PSU | 16,534 | $0 | — |
| PSU | 11,873 | $0 | — |
| Option | 158,454 | — | $22.77 |
| Option | 135,306 | — | $21.12 |
| Option | 82,668 | — | $14.15 |
Per the Outstanding Equity Awards at Fiscal Year-End table in CATALYST PHARMACEUTICALS, INC.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.
CATALYST PHARMACEUTICALS’s named executive officers, FY2024
as the company reported each| Named executive officer | Role | FY2024 total |
|---|---|---|
| Richard Daly | President and CEO | $7,774,160 |
| Michael Kalb | EVP and CFO | $6,180,936 |
| Steven Miller · this page | COO and CSO | $3,545,774 |
| Jeffrey Del Carmen | CCO | $2,638,127 |
| Preethi Sundaram | Chief Strategy Officer | $2,528,555 |
Steven Miller's compensation dossier, CATALYST PHARMACEUTICALS
You have read Steven Miller's totals and holdings. The dossier adds each equity grant CATALYST PHARMACEUTICALS disclosed for Steven Miller and CATALYST PHARMACEUTICALS's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.
See an example →The full CATALYST PHARMACEUTICALS compensation record
free company briefThis page is one person within CATALYST PHARMACEUTICALS's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the CATALYST PHARMACEUTICALS proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order CATALYST PHARMACEUTICALS's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are CATALYST PHARMACEUTICALS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.